CLASS II Device recall · Reported 21 Sep 2016 · FDA Enforcement Report

Hospira MedNet Medication Management Suite recalled

Hospira Inc. A Pfizer is recalling Hospira MedNet Medication Management Suite, distributed in 13 states. The recall was initiated on 28 Jul 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesList Numbers 16037-64-02 and 16037-64-03
Quantity recalled20

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2790-2016
FDA event ID
74903
Recalling firm
Hospira Inc. A Pfizer, Lake Forest, IL
Classification
Class II
Status
Terminated
Recall initiated
28 Jul 2016
FDA classified
13 Sep 2016
Reported
21 Sep 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Infusion Pumps

Timeline

28 Jul 2016Recall initiated by company
13 Sep 2016Classified by FDA+47 days
21 Sep 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Hospira MedNet 6.1 software, in combination with the SapphirePlus 13.1x infusion pump, may result in incorrect bolus amount calculations for drugs whose concentrations are listed in Million Units.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Hospira MedNet Medication Management Suite software, version 6.1, List Numbers 16037-64-02 and 16037-64-03, in combination with the SapphirePlus 13.1x infusion pump Hospira MedNet Medication Management Suite is intended to facilitate networked communication between compatible computer systems and Hospital infusion pumps.

Where it was distributed

Worldwide Distribution - US including ND, TX, MI, MN, WI, IA, ME, HI, PA, MA, NJ, NY, CT, and Internationally to Canada.

ConnecticutHawaiiIowaMassachusettsMaineMichiganMinnesotaNorth DakotaNew JerseyNew YorkPennsylvaniaTexasWisconsin

Questions about this recall

Why was it recalled?

Hospira MedNet 6.1 software, in combination with the SapphirePlus 13.1x infusion pump, may result in incorrect bolus amount calculations for drugs whose concentrations are listed in Million Units.

Which lots are affected?

List Numbers 16037-64-02 and 16037-64-03

Where was it sold?

Worldwide Distribution - US including ND, TX, MI, MN, WI, IA, ME, HI, PA, MA, NJ, NY, CT, and Internationally to Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hospira Inc. A Pfizer

All 9

Other Infusion Pumps recalls

All 549